相关实验视频
Updated: Jun 23, 2025
04:44
Developing a Rat Model for Bipolar Disorder
Published on: May 2, 2025
246
治疗精神病双极性抑郁症的挑战
Maité A Cintrón Pastrana1, Jessica C Irizarry Flores2, Anthony J Rothschild
1From the UMass Chan Medical School Department of Psychiatry, Worcester, MA.
Journal of clinical psychopharmacology
|June 20, 2024
概括
精神病性双极性抑郁症 (PBD) 治疗缺乏具体的指导方针. 虽然抗精神病药物是常见的,但将它们与抗抑郁药和情绪稳定剂相结合可能是有效的,但迫切需要更多的研究.
科学领域:
- 精神病学是一个精神病学.
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 精神病性双极性抑郁症 (PBD) 很常见,但研究不足,缺乏FDA批准的治疗方法或具体指南.
- 目前关于情绪稳定剂和抗精神病药物治疗双极性抑郁症的研究尚未明确它们对PBD的有效性.
- 需要进行专注的研究来改善PBD管理.
研究的目的:
- 审查和总结现有的关于精神病双极性抑郁症 (PBD) 治疗的文献.
- 突出目前在PBD管理中的挑战和知识差距.
主要方法:
- 从20世纪60年代到2023年进行了广泛的电子文献搜索.
- 这些数据库包括PubMed,MEDLINE,EMBASE和谷歌.
- 研究是根据它们与PBD的直接相关性来选择的.
主要成果:
- 双相情感障碍影响50%-75%的双相情感障碍患者,特别是那些先前患有精神病躁狂的人.
- 治疗通常涉及情绪稳定剂,抗精神病药物或ECT,但没有确立一线治疗方法.
- 尽管证据有限,但抗精神病药物经常被使用;与抗抑郁药和情绪稳定剂的组合显示出潜力.
结论:
- 由于其严重程度和缺乏治疗共识,PBD构成了重大的心理健康挑战.
- 迫切需要进行临床试验,以确定最佳的急性PBD治疗,随访和患者分层.
- 需要进行进一步的研究,以便为随后的PBD疗法开发有效的决策模型.
相关概念视频
01:26Psychosis: Goals of Pharmacotherapy
122
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
122
01:24Mania and Antimanic Drugs: Overview
168
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
168
01:28Psychosis and Antipsychotic Drugs: Overview
234
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
234
01:30Bipolar Disorder
65
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
65
01:28Drug Therapy
42
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
42
01:23Antidepressant Drugs: MAOIs and Other Agents
220
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
220